We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Trophos Successfully Completes Phase 1 Study for Novel Cardioprotective Compound, TRO40303

News   Feb 25, 2011

 
Trophos Successfully Completes Phase 1 Study for Novel Cardioprotective Compound, TRO40303
 
 
 

RELATED ARTICLES

Costs and Complications of Lung Cancer Diagnostic Tests Underestimated

News

This study underscores the importance of sharing risks with patients considering lung cancer screening.

READ MORE

Osteoarthritis Stem Cell Therapy Success in Phase I and II Trials

News

Details of a new therapy for the symptomatic treatment of osteoarthritis have been revealed, using mesenchymal cells from umbilical cord stroma.

READ MORE

Liver-on-chip Enables Real-time Cholesterol Measurement

News

A microfluidic liver-on-chip system which enables real-time measurement of cholesterol has been developed to study the effects of potentially cholesterol-lowering drugs in real time.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE